These results indicate that trastuzumab induces PUMA‐dependent apoptosis and inhibits tumor growth in GC, suggesting that PUMA plays a critical role in mediating the antitumor effects of trastuzumab in GC. The gene discussed is BBC3; the disease is neoplasm.